Statement of Cash Flows—Indirect Method
The comparative balance sheet of Livers Inc. for December 31, 20Y3 and 20Y2, is shown as follows:
Dec. 31, 20Y3 | Dec. 31, 20Y2 | ||||
Assets | |||||
Cash | $261,120 | $243,460 | |||
Accounts receivable (net) | 94,590 | 87,440 | |||
Inventories | 267,040 | 258,890 | |||
Investments | 0 | 100,300 | |||
Land | 136,970 | 0 | |||
Equipment | 294,620 | 228,890 | |||
Accumulated depreciation—equipment | (68,980) | (61,720) | |||
Total assets | $985,360 | $857,260 | |||
Liabilities and Stockholders' Equity | |||||
Accounts payable (merchandise creditors) | $178,350 | $168,880 | |||
Accrued expenses payable (operating expenses) | 17,740 | 22,290 | |||
Dividends payable | 9,850 | 7,720 | |||
Common stock, $10 par | 53,210 | 42,010 | |||
Paid-in capital: Excess of issue price over par-common stock | 200,030 | 116,590 | |||
Retained earnings | 526,180 | 499,770 | |||
Total liabilities and stockholders’ equity | $985,360 | $857,260 |
Additional data obtained from an examination of the accounts in the ledger for 20Y3 are as follows:
Required:
Prepare a statement of cash flows, using the indirect method of presenting cash flows from operating activities. Use the minus sign to indicate cash out flows, cash payments, decreases in cash, or any negative adjustments.
Livers Inc. | ||
Statement of Cash Flows | ||
For the Year Ended December 31, 20Y3 | ||
Cash flows from operating activities: | ||
$ | ||
Adjustments to reconcile net income to net cash flow from operating activities: | ||
Changes in current operating assets and liabilities: | ||
Net cash flow from operating activities | $ | |
Cash flows from investing activities: | ||
$ | ||
Net cash flow used for investing activities | ||
Cash flows from financing activities: | ||
$ | ||
Net cash flow from financing activities | ||
$ | ||
Cash at the beginning of the year | ||
Cash at the end of the year | $ |
Working note 1 --Calculation of Cash Dividend paid | |||
Opening Balance of Dividends Payable | 7720.00 | ||
Add: Dividends Declared during the year | 40290.00 | ||
Total Dividend Liability | 48010.00 | ||
Less: Closing Balance of Dividends | 9850.00 | ||
Dividends Paid in cash During the year | 38160.00 | ||
Working note 2---Depreciation expense for the year | |||
Closing Balance of Accumulated depreciation on equipment | 68980.00 | ||
Less: Opening Balance of Accumulated depreciation onequipment | 61720.00 | ||
Depreciation for the Year | 7260.00 | ||
Statement of Cash Flows | |||
For the Year Ended December 31,20Y3 | |||
A. Cash Flows from Operating Activity | |||
Net Income | 66700.00 | ||
Adjustments to reconcile net income to net cash flow fromoperating activities: | |||
Depreciation expense | 7260.00 | 7260 | |
Profit on sale of Investment ( 117350- 100300) | 17050.00 | -17050 | |
Changes in current operating assets and liabilities: | |||
Increase in Inventory (267,040- 258,890) | 8150.00 | -8150 | |
Increase in Accounts Payable (178350 - 168880) | 9470.00 | 9470 | |
Decrease in Accrued Expenses (17740- 22290) | -4550.00 | -4550 | |
Increase in Accounts Receivables ( 94590-87440) | 7150.00 | -7150 | |
Net cash flow from Operating activities | 46530.00 | ||
B. Cash flows from Investing Activities | |||
Purchase of Land | -136970.00 | ||
Sale of Investment | 117350.00 | ||
Purchase of Equipment | -65730.00 | ||
Net Cash Used for Investing activities | -85350.00 | ||
C. Cash Flows from Financing activities | |||
Proceeds from Additional Paid in capital | 83440.00 | ||
payments of dividends | -38160.00 | ||
Issue of Stock | 11200.00 | ||
Net Cash flows from Financing activities | 56480.00 | ||
Net Increase (Decrease) in Cash [A+B+C] | 17660.00 | ||
Cash at the beginning | 243460.00 | ||
Cash at the end | 261120.00 |
Statement of Cash Flows—Indirect Method The comparative balance sheet of Livers Inc. for December 31, 20Y3...
Statement of Cash Flows—Indirect Method The comparative balance sheet of Livers Inc. for December 31, 20Y3 and 20Y2, is shown as follows: Dec. 31, 20Y3 Dec. 31, 20Y2 Assets Cash $261,120 $243,460 Accounts receivable (net) 94,590 87,440 Inventories 267,040 258,890 Investments 0 100,300 Land 136,970 0 Equipment 294,620 228,890 Accumulated depreciation—equipment (68,980) (61,720) Total assets $985,360 $857,260 Liabilities and Stockholders' Equity Accounts payable (merchandise creditors) $178,350 $168,880 Accrued expenses payable (operating expenses) 17,740 22,290 Dividends payable 9,850 7,720 Common stock,...
Statement of Cash Flows—Indirect Method The comparative balance sheet of Livers Inc. for December 31, 20Y3 and 20Y2, is shown as follows: Dec. 31, 20Y3 Dec. 31, 20Y2 Assets Cash $253,630 $237,840 Accounts receivable (net) 91,880 85,420 Inventories 259,370 252,910 Investments 0 97,980 Land 133,030 0 Equipment 286,170 223,600 Accumulated depreciation—equipment (67,000) (60,300) Total assets $957,080 $837,450 Liabilities and Stockholders' Equity Accounts payable (merchandise creditors) $173,230 $164,980 Accrued expenses payable (operating expenses) 17,230 21,770 Dividends payable 9,570 7,540 Common stock,...
Statement of Cash Flows—Indirect Method The comparative balance sheet of Livers Inc. for December 31, 20Y3 and 20Y2, is shown as follows: Dec. 31, 20Y3 Dec. 31, 20Y2 Assets Cash $244,600 $230,160 Accounts receivable (net) 88,610 82,660 Inventories 250,140 244,740 Investments 0 94,820 Land 128,300 0 Equipment 275,980 216,380 Accumulated depreciation—equipment (64,610) (58,350) Total assets $923,020 $810,410 Liabilities and Stockholders' Equity Accounts payable (merchandise creditors) $167,070 $159,650 Accrued expenses payable (operating expenses) 16,610 21,070 Dividends payable 9,230 7,290 Common stock,...
Statement of Cash Flows-Indirect Method The comparative balance sheet of Livers Inc. for December 31, 2013 and 20Y2, is shown as follows: Dec. 31, 20Y3 Dec. 31, 2012 Assets Cash Accounts receivable (net) $251,660 91,170 257,350 $235,180 84,470 250,070 96,890 Inventories Investments 0 Land 221,100 Equipment Accumulated depreciation equipment 132,000 283,950 (66,480) $949,650 (59,620) $828,090 Total assets Liabilities and Stockholders' Equity Accounts payable (merchandise creditors) Accrued expenses payable (operating expenses) $171,890 17,090 9,500 $163,130 21,530 7,450 40,580 Dividends payable Common...
he comparative balance sheet of Livers Inc. for December 31, 20Y3 and 20Y2, is shown as follows: Dec. 31, 20Y3 Dec. 31, 20Y2 Assets Cash $270,970 $250,900 Accounts receivable (net) 98,160 90,110 Inventories 277,110 266,820 Investments 0 103,360 Land 142,130 0 Equipment 305,730 235,880 Accumulated depreciation—equipment (71,580) (63,610) Total assets $1,022,520 $883,460 Liabilities and Stockholders' Equity Accounts payable (merchandise creditors) $185,080 $174,040 Accrued expenses payable (operating expenses) 18,410 22,970 Dividends payable 10,230 7,950 Common stock, $10 par 55,220 43,290 Paid-in...
Statement of Cash Flows-Indirect Method The comparative balance sheet of Livers Inc. for December 31, 20Y3 and 20Y2, is shown as follows: Dec. 31, 20Y3 Dec. 31, 20Y2 Assets Cash $260,120 $240,850 Accounts receivable (net) 94,230 86,500 Inventories 266,000 256,120 Investments 0 99,230 Land 136,440 0 Equipment 293,490 226,440 Accumulated depreciation-equipment (68,710) (61,060) Total assets $981,570 $848,080 Liabilities and Stockholders' Equity Accounts payable (merchandise creditors) $177,660 $167,070 Accrued expenses payable (operating expenses) 17,670 22,050 Dividends payable 9,820 7,630 Common stock,...
Instructions The comparative balance sheet of Livers Inc. for December 31, 20Y3 and 20Y2, is shown as follows: Dec. 31, 20Y3 Dec. 31, 20Y2 Assets 3 Cash $626,640.00 $585,760.00 Accounts receivable (net) 226,900.00 208,390.00 Inventories 641,350.00 616,130.00 Investments 0.00 239,300.00 Land 328,730.00 0.00 Equipment 705,940.00 Accumulated depreciation-equipment (166,970.00) 553,530.00 (148,000.00) $2,055,110.00 Total assets $2,362,590.00 Liabilities and Stockholders' Equity 12 Accounts payable (merchandise creditors) $425,140.00 $404,540.00 13 Accrued expenses payable (operating expenses) 42,020.00 52,750.00 Dividends payable 23,580.00 19,500.00 Common stock, $4...
Statement of Cash Flows—Indirect Method The comparative balance sheet of Olson-Jones Industries Inc. for December 31, 20Y2 and 20Y1, is as follows: Dec. 31, 20Y2 Dec. 31, 20Y1 Assets Cash $183 $14 Accounts receivable (net) 55 49 Inventories 117 99 Land 250 330 Equipment 205 175 Accumulated depreciation—equipment (68) (42) Total assets $742 $625 Liabilities and Stockholders' Equity Accounts payable (merchandise creditors) $51 $37 Dividends payable 5 - Common stock, $1 par 125 80 Paid-in capital in excess of par—common...
Statement of Cash Flows—Indirect Method The comparative balance sheet of Olson-Jones Industries Inc. for December 31, 20Y2 and 20Y1, is as follows: Dec. 31, 20Y2 Dec. 31, 20Y1 Assets Cash $192 $61 Accounts receivable (net) 109 76 Inventories 68 42 Land 156 172 Equipment 88 67 Accumulated depreciation-equipment (24) (12) Total Assets $589 $406 Liabilities and Stockholders' Equity Accounts payable (merchandise creditors) $74 $61 Dividends payable 12 - Common stock, $10 par 39 19 Paid-in capital: Excess of issue price...
Statement of Cash Flows—Indirect Method The comparative balance sheet of Olson-Jones Industries Inc. for December 31, 20Y2 and 20Y1, is as follows: Dec. 31, 20Y2 Dec. 31, 20Y1 Assets Cash $203 $65 Accounts receivable (net) 116 81 Inventories 73 44 Land 166 184 Equipment 93 71 Accumulated depreciation-equipment (25) (13) Total Assets $626 $432 Liabilities and Stockholders' Equity Accounts payable (merchandise creditors) $79 $65 Dividends payable 13 - Common stock, $10 par 41 20 Paid-in capital: Excess of issue price...